Medical

barbituric acid

Also found in: Dictionary, Encyclopedia, Wikipedia.

barbituric acid

 [bahr″bi-tu´rik]
the parent substance of the barbiturates, not itself a central nervous system depressant.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

bar·bi·tu·ric ac·id

(bar'bi-chūr'ik as'id),
A crystalline dibasic acid from which barbital and other barbiturates are derived; has no sedative action.
Synonym(s): malonylurea
Farlex Partner Medical Dictionary © Farlex 2012

barbituric acid

(bär′bĭ-to͝or′ĭk, -tyo͝or′-)
n.
An acidic pyrimidine derivative, C4H4O3N2, used in the manufacture of barbiturates and some plastics.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.

bar·bi·tu·ric ac·id

(bar'bi-chūr'ik as'id)
A nonsedating crystalline dibasic acid from which barbital and other barbiturates are derived.
Medical Dictionary for the Dental Professions © Farlex 2012
Mentioned in
References in periodicals archive
5-(2-chloro-6-methylquinolin-3-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-trione (3bm): Dark orange solid; M.F: [C.sub.15][H.sub.10]Cl[N.sub.3][O.sub.3]; Mp (C) 295-298[degrees]C; [sup.1]HNMR(DMSO-[d.sub.6], 400MHz) [delta] (ppm): 2.35(s,3H, C[H.sub.3]), 7.27-8.51 (m, 4H, Ar-H), 9.10(s, 1H, vinyl CH), 11.31(broad S, 2H, NH); [sup.13]CNMR (DMSO-[d.sub.6], 100 MHz) [delta] (ppm): 21.34 (C[H.sub.3]), 125.50, 134.34, 136.23, 135.78, 130.55, 145.77, 150.44 (Arc), 150.45(C=CH), 124.54, 160.09, 162.73(C of barbituric acid), 124.33, 167.56, 178.59; m/z = (315) 338 [[M+Na].sup.+]; Found, %: C 57.04, H 3.16, N 13.29; Calculated, % : C 57.06, H 3.19, Cl 11.23, N 13.31.
5-(2-chloro-6-methylquinolin-3-yl)methylene)dihydro-2-thioxopyrimidine-4,6(1H,5H)-dione (3bn): Cream solid; M.F.: [C.sub.15][H.sub.10]Cl[N.sub.3][O.sub.2]S.; Mp (C) 280-282; [sup.1]HNMR(DMSO-[d.sub.6], 400MHz) [delta] (ppm): 2.35 (s,3H,C[H.sub.3]), 7.47-8.03(m, 4H, ArH), 8.01 (s,1H, vinyl CH), 8.15 (Broad S, 2H, NH); [sup.13]CNMR (DMSO-[d.sub.6],100 MHz) [delta] (ppm): 24.36(CHa), 126.45, 132.38, 136.77, 135.89, 130.54, 145.14, 148.33(Arc), 148.80(C=CH), 124.56, 150.67, 165.34, (C of barbituric acid), 124.55, 167.43, 178.45; Mass spectrum, m/z = 331 [M] +.
Effects of various solvents on the knoevenagel condensation between Indole-3- carboxaldehyde and Barbituric acid at 60[degrees]C.
The direct barbituric acid assay for nicotine metabolites in urine: a simple colorimetric test for routine assessment of smoking status and cigarette intake.
2-cyano-3-phenyl-N-[(2,4,6- trioxotetrahydropyrimidin-5(2H)- ylidene)methyl]prop-2-enamide(2) Yield 66%, yellow solid, m.p.260-262C; 1H NMR (d6-DMSO, d, ppm); 12.44 (1H, d, J 12.0 , =CHNH-), 11.49 (1H, s, NH barbituric acid), 11.36 (1H, s, NH barbituric acid), 8.53 (1H, d, J 11.7, =CHNH- ), 8.26 (1H, s, Ar-CH=C(CN)CO), 8.14 (2H, d, J, 9.0, ArH), 8.10 (1H, m, J 7.5, ArH), 7.63 (2H, m, J 7.5, ArH), 13C NMR (d6-DMSO, d, ppm): 165.9 (CO), 164.9 (CO), 162.7 (CO), 159.8 (CO), 154.7 (CH), 150.6 (CH), 149.9 (C), 148.9 (C), 146.0 (C), 134.0 (CH), 133.0 (CH), 132.3 (CH), 131.2 (CH), 128.2 (CH), 100.8 (C); MS (EI) m/z % 310 (M+9), 170.0 (41), 156.0 (100), 128.0 (64), 77.0 (36); Anal.
Yield 66%, yellow solid, m.p.334-336C; 1H NMR (d6-DMSO, d, ppm); 12.43 (1H, d, J 8.7, =CHNH-), 11.44 (1H, s, NH barbituric acid ), 11.27 (1H, s, NH barbituri acid ), 10.65 (1H, s, broad, phenolic), 8.48 (1H, d, J 8.7, =CHNH- ), 8.41 (1H, s, Ar-CH=C(CN)CO-), 8.05 (2H, d, J 8.4, ArH), 6.97 (2H, d, J 8.4, ArH); 13C NMR (d6-DMSO, d, ppm): 165.9 (CO), 164.2 (CO), 163.8 (CO), 162.6 (CO), 160.4 (C-O), 155.7 (CH), 150.3 (CH), 148.7 (CH), 146.3 (CH), 134.7 (CH), 122.7 (C), 116.7 (CH), 116.2 (C), 100.2 (C), 97.1 (C); MS (EI) m/z % 326.0 (M+ 70), 186 (11.6), 172 (100), 155 (7.2), 144 (46.0), 116 (18), 89 (23); Anal.
Yield 65%, light yellow solid, m.p.320322C; 1HNMR (d6-DMSO, d, ppm); 12.44 (1H, d, J 11.7,=CHNH-), 11.42 (1H, s, NH barbituric acid), 11.28 (1H, s, NH barbituric acid), 10.18 (1H, s, broad, phenolic), 9.45 (1H, d, J11.4, =CH-NH), 8.46 (1H, s, Ar-CH=C(CN)CO-), 8.12 (1H, d, J 6.9, ArH), 7.96 (1H, d, J 7.2, ArH), 7.78 (1H, d, J 7.2, ArH), 7.47 (1H, d, J 7.5, ArH); 13C NMR (d6-DMSO, d, ppm): 169.7 (CO) 167.6 (CO), 165.8 (CO), 164.0 (CO), 157.8 (CH), 150.0 (C), 147.7 (CH), 134.0 (CH), 130.1 (CH), 127.5 (CH), 125.0 (C), 118.4 (C), 116.0 (CH), 100.2 (C), 90.2 (C); MS (EI) m/z 326(M+ 0), 199 (27), 188 (38), 171 (72), 155 (76), 143 (71), 128 (100), 100 (16), 89 (44), 85 (57); Anal.
Over 2500 derivatives of barbituric acid have been synthesized after the triumph of barbital and phenobarbital in epilepsy.
Eighteen derivatives (1-18) were synthesized from commercially available barbituric acid by condensation with various aldehydes at 100 degC in water.
Interestingly, we found compounds 16-18 as cyclic chromenopyrimidine diones which were earlier reported by our research group as antioxidant and cytotoxic derivatives of barbituric acid [8].
In the present study, we synthesized a series of N,N'-dimethylbarbituric acid derivatives 1-24, structurally close to allopurinol (25), with one of its rings resembled to barbituric acid (Fig.
The basic hypothesis was that an amide bond and a six member aromatic ring in the allupurinol and barbituric acid, respectively, may exhibit inhibitory potential against the xanthine oxidase.
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.